Western Wealth Management’s ACELYRIN SLRN Stock Holding History

Western Wealth Management’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$61.8K	–	745
2025 Q1	$61.8K	Buy	+25,000	New	+$59.4K	﹤0.01%	671

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Western Wealth Management's SLRN Position: Q2 2025 in Review

Western Wealth Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 25,000 shares — an estimated $61.8K sold.

Western Wealth Management first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $61.8K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Western Wealth Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Western Wealth Management sold 25,000 ACELYRIN shares in Q2 2025, an estimated $61.8K.
Western Wealth Management first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
Western Wealth Management's ACELYRIN position peaked at $61.8K in Q1 2025.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Western Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.